Plasmid DNA Manufacturing Market Size Is Expected To Reach USD 5,899.5 Million By 2030
San Francisco, 4 Aug 2023: The Report Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D, GMP), By Application, By Development Phase, And Segment Forecasts, 2023 - 2030 The global plasmid DNA manufacturing market size is expected to reach USD 5,899.5 million by 2030, registering a CAGR of 17.63% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, combined with the wide application scope of plasmid DNA in the healthcare industry is expected to drive the industry growth. Plasmid DNA can be used directly for therapeutic applications, such as the production of vaccine antigens or gene therapy. Moreover, it can be utilized for various research purposes, such as gene cloning, gene mapping, etc. The rising number of patients choosing gene therapy is expected to drive industry growth in the coming years. According to clinicaltrials.gov,